nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—Tonic-clonic seizures—Carmustine—melanoma	0.0202	0.0469	CcSEcCtD
Vidarabine—Adenosine triphosphate—APAF1—melanoma	0.0131	0.373	CrCbGaD
Vidarabine—Intracranial pressure increased—Carmustine—melanoma	0.013	0.0302	CcSEcCtD
Vidarabine—Haemorrhage intracranial—Temozolomide—melanoma	0.0128	0.0297	CcSEcCtD
Vidarabine—Grand mal convulsion—Carmustine—melanoma	0.0114	0.0265	CcSEcCtD
Vidarabine—Glucosamine—IFNG—melanoma	0.0087	0.247	CrCbGaD
Vidarabine—Sinus tachycardia—Docetaxel—melanoma	0.00866	0.0201	CcSEcCtD
Vidarabine—Atrial fibrillation—Vemurafenib—melanoma	0.00786	0.0183	CcSEcCtD
Vidarabine—Burning sensation—Carmustine—melanoma	0.00781	0.0182	CcSEcCtD
Vidarabine—Scotoma—Carmustine—melanoma	0.00715	0.0166	CcSEcCtD
Vidarabine—Scotoma—Temozolomide—melanoma	0.00691	0.0161	CcSEcCtD
Vidarabine—Glucosamine—MMP9—melanoma	0.00554	0.157	CrCbGaD
Vidarabine—Injection site reaction—Carmustine—melanoma	0.0054	0.0126	CcSEcCtD
Vidarabine—Respiratory failure—Temozolomide—melanoma	0.00534	0.0124	CcSEcCtD
Vidarabine—Burning sensation—Docetaxel—melanoma	0.00502	0.0117	CcSEcCtD
Vidarabine—Cardiac disorder—Vemurafenib—melanoma	0.00478	0.0111	CcSEcCtD
Vidarabine—Mediastinal disorder—Vemurafenib—melanoma	0.00465	0.0108	CcSEcCtD
Vidarabine—Cerebrovascular accident—Bleomycin—melanoma	0.00461	0.0107	CcSEcCtD
Vidarabine—Scotoma—Docetaxel—melanoma	0.00459	0.0107	CcSEcCtD
Vidarabine—Dysgeusia—Vemurafenib—melanoma	0.00439	0.0102	CcSEcCtD
Vidarabine—Back pain—Vemurafenib—melanoma	0.00434	0.0101	CcSEcCtD
Vidarabine—Myocardial ischaemia—Docetaxel—melanoma	0.00434	0.0101	CcSEcCtD
Vidarabine—Nasal congestion—Temozolomide—melanoma	0.00418	0.00972	CcSEcCtD
Vidarabine—Chest discomfort—Docetaxel—melanoma	0.00394	0.00917	CcSEcCtD
Vidarabine—Cough—Vemurafenib—melanoma	0.00392	0.00911	CcSEcCtD
Vidarabine—Bronchospasm—Bleomycin—melanoma	0.00384	0.00893	CcSEcCtD
Vidarabine—Affect lability—Temozolomide—melanoma	0.00375	0.00872	CcSEcCtD
Vidarabine—Anaphylactic shock—Vemurafenib—melanoma	0.00366	0.00852	CcSEcCtD
Vidarabine—Glucosamine—TNF—melanoma	0.00364	0.103	CrCbGaD
Vidarabine—Mood swings—Temozolomide—melanoma	0.00361	0.00839	CcSEcCtD
Vidarabine—Adenosine triphosphate—AKT1—melanoma	0.00357	0.101	CrCbGaD
Vidarabine—Respiratory failure—Docetaxel—melanoma	0.00355	0.00826	CcSEcCtD
Vidarabine—Blood pressure increased—Docetaxel—melanoma	0.00349	0.00811	CcSEcCtD
Vidarabine—Injection site reaction—Docetaxel—melanoma	0.00347	0.00807	CcSEcCtD
Vidarabine—Acute coronary syndrome—Bleomycin—melanoma	0.00343	0.00798	CcSEcCtD
Vidarabine—Hypotension—Vemurafenib—melanoma	0.00342	0.00796	CcSEcCtD
Vidarabine—Myocardial infarction—Bleomycin—melanoma	0.00341	0.00793	CcSEcCtD
Vidarabine—DPP4—blood vessel—melanoma	0.00338	0.183	CbGeAlD
Vidarabine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00334	0.00776	CcSEcCtD
Vidarabine—Lightheadedness—Docetaxel—melanoma	0.00312	0.00726	CcSEcCtD
Vidarabine—Hypoaesthesia—Bleomycin—melanoma	0.00311	0.00723	CcSEcCtD
Vidarabine—Pollakiuria—Temozolomide—melanoma	0.00304	0.00707	CcSEcCtD
Vidarabine—Flushing—Bleomycin—melanoma	0.0029	0.00674	CcSEcCtD
Vidarabine—Hypoaesthesia—Carmustine—melanoma	0.00271	0.00631	CcSEcCtD
Vidarabine—Flushing—Dactinomycin—melanoma	0.0027	0.00629	CcSEcCtD
Vidarabine—Hypersensitivity—Vemurafenib—melanoma	0.0027	0.00628	CcSEcCtD
Vidarabine—Atrial fibrillation—Docetaxel—melanoma	0.00267	0.00622	CcSEcCtD
Vidarabine—Asthenia—Vemurafenib—melanoma	0.00263	0.00611	CcSEcCtD
Vidarabine—Hypoaesthesia—Temozolomide—melanoma	0.00262	0.0061	CcSEcCtD
Vidarabine—Cardiac failure—Docetaxel—melanoma	0.0026	0.00604	CcSEcCtD
Vidarabine—Flushing—Carmustine—melanoma	0.00253	0.00588	CcSEcCtD
Vidarabine—Tinnitus—Temozolomide—melanoma	0.00246	0.00571	CcSEcCtD
Vidarabine—Cardiac disorder—Temozolomide—melanoma	0.00245	0.00569	CcSEcCtD
Vidarabine—Flushing—Temozolomide—melanoma	0.00245	0.00569	CcSEcCtD
Vidarabine—Arrhythmia—Carmustine—melanoma	0.00244	0.00566	CcSEcCtD
Vidarabine—Dizziness—Vemurafenib—melanoma	0.00242	0.00563	CcSEcCtD
Vidarabine—Mediastinal disorder—Temozolomide—melanoma	0.00237	0.00552	CcSEcCtD
Vidarabine—Cough—Bleomycin—melanoma	0.00237	0.00552	CcSEcCtD
Vidarabine—Vomiting—Vemurafenib—melanoma	0.00233	0.00542	CcSEcCtD
Vidarabine—Chest pain—Bleomycin—melanoma	0.00231	0.00538	CcSEcCtD
Vidarabine—Rash—Vemurafenib—melanoma	0.00231	0.00537	CcSEcCtD
Vidarabine—Dermatitis—Vemurafenib—melanoma	0.00231	0.00537	CcSEcCtD
Vidarabine—Back pain—Carmustine—melanoma	0.0023	0.00534	CcSEcCtD
Vidarabine—Headache—Vemurafenib—melanoma	0.00229	0.00534	CcSEcCtD
Vidarabine—Discomfort—Bleomycin—melanoma	0.00229	0.00532	CcSEcCtD
Vidarabine—Dysgeusia—Temozolomide—melanoma	0.00225	0.00522	CcSEcCtD
Vidarabine—Vision blurred—Carmustine—melanoma	0.00224	0.0052	CcSEcCtD
Vidarabine—Tremor—Carmustine—melanoma	0.00222	0.00517	CcSEcCtD
Vidarabine—Anaphylactic shock—Bleomycin—melanoma	0.00222	0.00516	CcSEcCtD
Vidarabine—Back pain—Temozolomide—melanoma	0.00222	0.00516	CcSEcCtD
Vidarabine—Agitation—Carmustine—melanoma	0.00218	0.00507	CcSEcCtD
Vidarabine—Nausea—Vemurafenib—melanoma	0.00218	0.00506	CcSEcCtD
Vidarabine—Vision blurred—Temozolomide—melanoma	0.00216	0.00503	CcSEcCtD
Vidarabine—Bronchospasm—Docetaxel—melanoma	0.00215	0.00501	CcSEcCtD
Vidarabine—Tremor—Temozolomide—melanoma	0.00215	0.005	CcSEcCtD
Vidarabine—Discomfort—Dactinomycin—melanoma	0.00213	0.00496	CcSEcCtD
Vidarabine—Agitation—Temozolomide—melanoma	0.00211	0.0049	CcSEcCtD
Vidarabine—Angioedema—Temozolomide—melanoma	0.0021	0.00487	CcSEcCtD
Vidarabine—Hypotension—Bleomycin—melanoma	0.00207	0.00482	CcSEcCtD
Vidarabine—Convulsion—Carmustine—melanoma	0.00206	0.00478	CcSEcCtD
Vidarabine—Hypertension—Carmustine—melanoma	0.00205	0.00477	CcSEcCtD
Vidarabine—Palpitations—Temozolomide—melanoma	0.00203	0.00471	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00202	0.0047	CcSEcCtD
Vidarabine—Chest pain—Carmustine—melanoma	0.00202	0.0047	CcSEcCtD
Vidarabine—Anxiety—Carmustine—melanoma	0.00201	0.00468	CcSEcCtD
Vidarabine—Cough—Temozolomide—melanoma	0.002	0.00465	CcSEcCtD
Vidarabine—Paraesthesia—Bleomycin—melanoma	0.00199	0.00463	CcSEcCtD
Vidarabine—Convulsion—Temozolomide—melanoma	0.00199	0.00462	CcSEcCtD
Vidarabine—Hypertension—Temozolomide—melanoma	0.00198	0.0046	CcSEcCtD
Vidarabine—Dyspnoea—Bleomycin—melanoma	0.00198	0.0046	CcSEcCtD
Vidarabine—Anxiety—Temozolomide—melanoma	0.00195	0.00453	CcSEcCtD
Vidarabine—Discomfort—Temozolomide—melanoma	0.00193	0.00449	CcSEcCtD
Vidarabine—Acute coronary syndrome—Docetaxel—melanoma	0.00192	0.00447	CcSEcCtD
Vidarabine—Myocardial infarction—Docetaxel—melanoma	0.00191	0.00445	CcSEcCtD
Vidarabine—Dry mouth—Temozolomide—melanoma	0.00191	0.00444	CcSEcCtD
Vidarabine—Pain—Bleomycin—melanoma	0.0019	0.00441	CcSEcCtD
Vidarabine—Tachycardia—Carmustine—melanoma	0.00189	0.0044	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00189	0.00438	CcSEcCtD
Vidarabine—Anaphylactic shock—Temozolomide—melanoma	0.00187	0.00435	CcSEcCtD
Vidarabine—ADK—retina—melanoma	0.00184	0.0998	CbGeAlD
Vidarabine—Hypotension—Carmustine—melanoma	0.00181	0.00421	CcSEcCtD
Vidarabine—Hyperhidrosis—Temozolomide—melanoma	0.00181	0.00421	CcSEcCtD
Vidarabine—ADA—mammalian vulva—melanoma	0.0018	0.0978	CbGeAlD
Vidarabine—Pain—Dactinomycin—melanoma	0.00177	0.00412	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Carmustine—melanoma	0.00176	0.0041	CcSEcCtD
Vidarabine—Urticaria—Bleomycin—melanoma	0.00176	0.0041	CcSEcCtD
Vidarabine—Hypoaesthesia—Docetaxel—melanoma	0.00174	0.00405	CcSEcCtD
Vidarabine—Paraesthesia—Carmustine—melanoma	0.00174	0.00404	CcSEcCtD
Vidarabine—Dyspnoea—Carmustine—melanoma	0.00173	0.00402	CcSEcCtD
Vidarabine—Somnolence—Carmustine—melanoma	0.00172	0.004	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00171	0.00397	CcSEcCtD
Vidarabine—Paraesthesia—Temozolomide—melanoma	0.00168	0.00391	CcSEcCtD
Vidarabine—Dyspnoea—Temozolomide—melanoma	0.00167	0.00388	CcSEcCtD
Vidarabine—Somnolence—Temozolomide—melanoma	0.00166	0.00387	CcSEcCtD
Vidarabine—Pain—Carmustine—melanoma	0.00166	0.00385	CcSEcCtD
Vidarabine—Hypersensitivity—Bleomycin—melanoma	0.00163	0.0038	CcSEcCtD
Vidarabine—Flushing—Docetaxel—melanoma	0.00163	0.00378	CcSEcCtD
Vidarabine—Cardiac disorder—Docetaxel—melanoma	0.00163	0.00378	CcSEcCtD
Vidarabine—ADK—skin of body—melanoma	0.00161	0.0876	CbGeAlD
Vidarabine—Pain—Temozolomide—melanoma	0.0016	0.00372	CcSEcCtD
Vidarabine—Asthenia—Bleomycin—melanoma	0.00159	0.0037	CcSEcCtD
Vidarabine—Mediastinal disorder—Docetaxel—melanoma	0.00158	0.00367	CcSEcCtD
Vidarabine—Arrhythmia—Docetaxel—melanoma	0.00157	0.00364	CcSEcCtD
Vidarabine—Hypersensitivity—Dactinomycin—melanoma	0.00152	0.00355	CcSEcCtD
Vidarabine—Dysgeusia—Docetaxel—melanoma	0.00149	0.00347	CcSEcCtD
Vidarabine—Urticaria—Temozolomide—melanoma	0.00149	0.00346	CcSEcCtD
Vidarabine—Asthenia—Dactinomycin—melanoma	0.00148	0.00345	CcSEcCtD
Vidarabine—Back pain—Docetaxel—melanoma	0.00148	0.00343	CcSEcCtD
Vidarabine—ADK—mammalian vulva—melanoma	0.00147	0.0799	CbGeAlD
Vidarabine—Hypersensitivity—Carmustine—melanoma	0.00143	0.00332	CcSEcCtD
Vidarabine—DPP4—mammalian vulva—melanoma	0.00143	0.0775	CbGeAlD
Vidarabine—Vomiting—Bleomycin—melanoma	0.00141	0.00328	CcSEcCtD
Vidarabine—Rash—Bleomycin—melanoma	0.0014	0.00325	CcSEcCtD
Vidarabine—Dermatitis—Bleomycin—melanoma	0.0014	0.00325	CcSEcCtD
Vidarabine—Asthenia—Carmustine—melanoma	0.00139	0.00323	CcSEcCtD
Vidarabine—Hypersensitivity—Temozolomide—melanoma	0.00138	0.00321	CcSEcCtD
Vidarabine—Syncope—Docetaxel—melanoma	0.00137	0.00318	CcSEcCtD
Vidarabine—Palpitations—Docetaxel—melanoma	0.00135	0.00313	CcSEcCtD
Vidarabine—Asthenia—Temozolomide—melanoma	0.00134	0.00312	CcSEcCtD
Vidarabine—Loss of consciousness—Docetaxel—melanoma	0.00134	0.00312	CcSEcCtD
Vidarabine—Cough—Docetaxel—melanoma	0.00133	0.0031	CcSEcCtD
Vidarabine—Convulsion—Docetaxel—melanoma	0.00132	0.00307	CcSEcCtD
Vidarabine—Nausea—Bleomycin—melanoma	0.00132	0.00307	CcSEcCtD
Vidarabine—Hypertension—Docetaxel—melanoma	0.00132	0.00306	CcSEcCtD
Vidarabine—Vomiting—Dactinomycin—melanoma	0.00132	0.00306	CcSEcCtD
Vidarabine—Rash—Dactinomycin—melanoma	0.0013	0.00303	CcSEcCtD
Vidarabine—Chest pain—Docetaxel—melanoma	0.0013	0.00302	CcSEcCtD
Vidarabine—ADA—head—melanoma	0.00129	0.07	CbGeAlD
Vidarabine—Dizziness—Carmustine—melanoma	0.00128	0.00298	CcSEcCtD
Vidarabine—Dry mouth—Docetaxel—melanoma	0.00127	0.00295	CcSEcCtD
Vidarabine—Anaphylactic shock—Docetaxel—melanoma	0.00124	0.00289	CcSEcCtD
Vidarabine—Dizziness—Temozolomide—melanoma	0.00124	0.00288	CcSEcCtD
Vidarabine—Vomiting—Carmustine—melanoma	0.00123	0.00286	CcSEcCtD
Vidarabine—Nausea—Dactinomycin—melanoma	0.00123	0.00286	CcSEcCtD
Vidarabine—Shock—Docetaxel—melanoma	0.00122	0.00285	CcSEcCtD
Vidarabine—Rash—Carmustine—melanoma	0.00122	0.00284	CcSEcCtD
Vidarabine—Dermatitis—Carmustine—melanoma	0.00122	0.00284	CcSEcCtD
Vidarabine—Tachycardia—Docetaxel—melanoma	0.00121	0.00283	CcSEcCtD
Vidarabine—Headache—Carmustine—melanoma	0.00121	0.00282	CcSEcCtD
Vidarabine—Vomiting—Temozolomide—melanoma	0.00119	0.00277	CcSEcCtD
Vidarabine—Rash—Temozolomide—melanoma	0.00118	0.00274	CcSEcCtD
Vidarabine—Dermatitis—Temozolomide—melanoma	0.00118	0.00274	CcSEcCtD
Vidarabine—Headache—Temozolomide—melanoma	0.00117	0.00273	CcSEcCtD
Vidarabine—ADORA2A—head—melanoma	0.00117	0.0637	CbGeAlD
Vidarabine—Hypotension—Docetaxel—melanoma	0.00116	0.0027	CcSEcCtD
Vidarabine—Nausea—Carmustine—melanoma	0.00115	0.00268	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00113	0.00264	CcSEcCtD
Vidarabine—Paraesthesia—Docetaxel—melanoma	0.00112	0.0026	CcSEcCtD
Vidarabine—Nausea—Temozolomide—melanoma	0.00111	0.00259	CcSEcCtD
Vidarabine—Dyspnoea—Docetaxel—melanoma	0.00111	0.00258	CcSEcCtD
Vidarabine—Somnolence—Docetaxel—melanoma	0.00111	0.00257	CcSEcCtD
Vidarabine—Pain—Docetaxel—melanoma	0.00106	0.00248	CcSEcCtD
Vidarabine—ADK—head—melanoma	0.00105	0.0572	CbGeAlD
Vidarabine—DPP4—head—melanoma	0.00102	0.0554	CbGeAlD
Vidarabine—Hypersensitivity—Docetaxel—melanoma	0.000917	0.00213	CcSEcCtD
Vidarabine—ADA—lymph node—melanoma	0.000901	0.049	CbGeAlD
Vidarabine—Asthenia—Docetaxel—melanoma	0.000893	0.00208	CcSEcCtD
Vidarabine—Dizziness—Docetaxel—melanoma	0.000823	0.00191	CcSEcCtD
Vidarabine—Vomiting—Docetaxel—melanoma	0.000791	0.00184	CcSEcCtD
Vidarabine—Rash—Docetaxel—melanoma	0.000785	0.00183	CcSEcCtD
Vidarabine—Dermatitis—Docetaxel—melanoma	0.000784	0.00182	CcSEcCtD
Vidarabine—Headache—Docetaxel—melanoma	0.00078	0.00181	CcSEcCtD
Vidarabine—Nausea—Docetaxel—melanoma	0.000739	0.00172	CcSEcCtD
Vidarabine—ADK—lymph node—melanoma	0.000736	0.04	CbGeAlD
Vidarabine—DPP4—lymph node—melanoma	0.000714	0.0388	CbGeAlD
Vidarabine—Adenosine triphosphate—ABCB1—melanoma	0.000623	0.0177	CrCbGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM3—melanoma	0.000594	0.00115	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—MC1R—melanoma	0.000591	0.00115	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—melanoma	0.00059	0.00114	CbGpPWpGaD
Vidarabine—ADK—Metabolism—FASN—melanoma	0.000588	0.00114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TAS2R60—melanoma	0.000579	0.00112	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SLC5A5—melanoma	0.000578	0.00112	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MMP1—melanoma	0.000575	0.00111	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—RAC1—melanoma	0.000571	0.00111	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PLA2G6—melanoma	0.00057	0.0011	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GRM1—melanoma	0.000567	0.0011	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR7—melanoma	0.000567	0.0011	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—KISS1—melanoma	0.000563	0.00109	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GNAQ—melanoma	0.000558	0.00108	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CD44—melanoma	0.000558	0.00108	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAP2K1—melanoma	0.000556	0.00108	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CD—melanoma	0.000552	0.00107	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCR1—melanoma	0.000545	0.00106	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MC1R—melanoma	0.000537	0.00104	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP1B1—melanoma	0.000535	0.00104	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF2—melanoma	0.000528	0.00102	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RHOB—melanoma	0.000516	0.000999	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR7—melanoma	0.000515	0.000997	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GRM1—melanoma	0.000515	0.000997	CbGpPWpGaD
Vidarabine—ADA—Metabolism—VCAN—melanoma	0.000512	0.000992	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—TP53—melanoma	0.000504	0.000975	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—melanoma	0.000494	0.000957	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—melanoma	0.000487	0.000944	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CD80—melanoma	0.000484	0.000937	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—KIT—melanoma	0.000483	0.000935	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CB—melanoma	0.000481	0.000932	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—EGF—melanoma	0.000477	0.000924	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCR2—melanoma	0.00047	0.00091	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RHOB—melanoma	0.000468	0.000907	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—EDN1—melanoma	0.000466	0.000903	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RAC2—melanoma	0.000462	0.000895	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—IL6—melanoma	0.000461	0.000893	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGF1—melanoma	0.00046	0.000891	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—BRAF—melanoma	0.000454	0.000879	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—melanoma	0.000451	0.000874	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MMP2—melanoma	0.000445	0.000862	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ABCB1—melanoma	0.000441	0.000853	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLCB4—melanoma	0.000439	0.00085	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL1—melanoma	0.000439	0.00085	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP17A1—melanoma	0.000432	0.000837	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAP2K1—melanoma	0.000427	0.000827	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCR2—melanoma	0.000427	0.000826	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CD—melanoma	0.000424	0.000822	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PTEN—melanoma	0.000424	0.000821	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RAC2—melanoma	0.00042	0.000813	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—melanoma	0.000417	0.000807	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—melanoma	0.000416	0.000805	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—WNT5A—melanoma	0.000413	0.0008	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CUL3—melanoma	0.000413	0.000799	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TRRAP—melanoma	0.000413	0.000799	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GNA11—melanoma	0.000408	0.00079	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—FGF2—melanoma	0.000406	0.000787	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PRKCA—melanoma	0.000406	0.000785	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ERCC2—melanoma	0.000402	0.000779	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKR1B10—melanoma	0.000401	0.000777	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—F2R—melanoma	0.000399	0.000774	CbGpPWpGaD
Vidarabine—ADA—Metabolism—FASN—melanoma	0.000399	0.000773	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SLC5A5—melanoma	0.000393	0.000761	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—EDNRB—melanoma	0.000387	0.000749	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MDM2—melanoma	0.00038	0.000736	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GNAQ—melanoma	0.000379	0.000735	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CD44—melanoma	0.000379	0.000735	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—ERBB2—melanoma	0.000375	0.000726	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2RL1—melanoma	0.000373	0.000723	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—melanoma	0.000372	0.00072	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—melanoma	0.000371	0.000718	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CXCL8—melanoma	0.00037	0.000716	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CB—melanoma	0.00037	0.000716	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GAB2—melanoma	0.000365	0.000708	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNA11—melanoma	0.000365	0.000708	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP1B1—melanoma	0.000364	0.000704	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—F2R—melanoma	0.000363	0.000703	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK3—melanoma	0.000355	0.000688	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EDNRB—melanoma	0.000351	0.00068	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM3—melanoma	0.000351	0.000679	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CDKN1B—melanoma	0.000347	0.000672	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCR4—melanoma	0.000344	0.000665	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CTNNB1—melanoma	0.000341	0.000661	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CASP3—melanoma	0.00034	0.000659	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GNAQ—melanoma	0.00034	0.000658	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—melanoma	0.000338	0.000654	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—melanoma	0.000338	0.000654	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KISS1—melanoma	0.000333	0.000644	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GAB2—melanoma	0.000332	0.000643	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNA11—melanoma	0.000332	0.000643	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000331	0.000641	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCR1—melanoma	0.000322	0.000624	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SKI—melanoma	0.000322	0.000624	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CDKN1A—melanoma	0.00032	0.000621	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PTEN—melanoma	0.00032	0.000619	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—melanoma	0.000319	0.000618	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NFKB1—melanoma	0.000318	0.000616	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CG—melanoma	0.000318	0.000615	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MC1R—melanoma	0.000317	0.000614	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT3—melanoma	0.000313	0.000607	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCR4—melanoma	0.000312	0.000604	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GNAQ—melanoma	0.000308	0.000597	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARG—melanoma	0.000307	0.000594	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GRM1—melanoma	0.000304	0.000589	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR7—melanoma	0.000304	0.000589	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCB1—melanoma	0.0003	0.00058	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SUFU—melanoma	0.000296	0.000574	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—melanoma	0.000293	0.000568	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—melanoma	0.000289	0.00056	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—STAT3—melanoma	0.000286	0.000554	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NRAS—melanoma	0.000285	0.000552	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT3—melanoma	0.000285	0.000551	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CD—melanoma	0.000279	0.000541	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BCL2L11—melanoma	0.000277	0.000536	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RHOB—melanoma	0.000277	0.000536	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALB—melanoma	0.000276	0.000534	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PRKCA—melanoma	0.000276	0.000534	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ERCC2—melanoma	0.000273	0.000529	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK3—melanoma	0.000273	0.000529	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—melanoma	0.000271	0.000525	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HDAC6—melanoma	0.000266	0.000515	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—melanoma	0.000265	0.000513	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—EDN1—melanoma	0.000263	0.00051	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK1—melanoma	0.00026	0.000503	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—EGFR—melanoma	0.00026	0.000503	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—melanoma	0.00026	0.000503	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CSF2—melanoma	0.000257	0.000499	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCR2—melanoma	0.000252	0.000488	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—melanoma	0.000252	0.000488	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RAC2—melanoma	0.000248	0.00048	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCA—melanoma	0.000247	0.000478	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—KRAS—melanoma	0.000245	0.000475	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—WNT5A—melanoma	0.000244	0.000473	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFC—melanoma	0.000244	0.000473	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CB—melanoma	0.000243	0.000471	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—melanoma	0.000241	0.000467	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—melanoma	0.00024	0.000464	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EDN1—melanoma	0.000239	0.000463	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CSF2—melanoma	0.000234	0.000453	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RAC1—melanoma	0.000229	0.000443	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CA—melanoma	0.000226	0.000437	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCA—melanoma	0.000224	0.000434	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MAP2K2—melanoma	0.000219	0.000424	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CG—melanoma	0.000216	0.000418	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2R—melanoma	0.000214	0.000415	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTEN—melanoma	0.00021	0.000407	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—HRAS—melanoma	0.000209	0.000404	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—melanoma	0.000208	0.000404	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RAC1—melanoma	0.000208	0.000402	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDNRB—melanoma	0.000208	0.000402	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTK2B—melanoma	0.000201	0.00039	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—melanoma	0.0002	0.000387	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAB2—melanoma	0.000196	0.00038	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNA11—melanoma	0.000196	0.00038	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FLT1—melanoma	0.000195	0.000378	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CG—melanoma	0.000193	0.000374	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CD—melanoma	0.00019	0.000368	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALB—melanoma	0.000187	0.000363	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HDAC2—melanoma	0.000184	0.000357	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCR4—melanoma	0.000184	0.000357	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FOXO4—melanoma	0.000184	0.000357	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT1—melanoma	0.000184	0.000357	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GNAQ—melanoma	0.000182	0.000353	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CG—melanoma	0.000176	0.00034	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SYK—melanoma	0.000171	0.000332	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CD—melanoma	0.00017	0.000329	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGFR—melanoma	0.000168	0.000326	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ITGAV—melanoma	0.000168	0.000326	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT3—melanoma	0.000168	0.000326	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CB—melanoma	0.000165	0.00032	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—melanoma	0.000164	0.000317	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SOCS1—melanoma	0.000156	0.000302	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MAP2K1—melanoma	0.000155	0.000301	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—S100B—melanoma	0.000155	0.000301	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CD—melanoma	0.000154	0.000299	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ERBB4—melanoma	0.000149	0.000288	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CA—melanoma	0.000148	0.000287	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CB—melanoma	0.000148	0.000287	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN2B—melanoma	0.000147	0.000285	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTEN—melanoma	0.000143	0.000277	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CD86—melanoma	0.000142	0.000276	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—melanoma	0.000142	0.000276	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDN1—melanoma	0.000141	0.000274	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CSF2—melanoma	0.000138	0.000267	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGF1—melanoma	0.000138	0.000267	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2—melanoma	0.000136	0.000263	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—E2F1—melanoma	0.000135	0.000262	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CB—melanoma	0.000135	0.00026	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDGFRA—melanoma	0.000134	0.000259	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCA—melanoma	0.000132	0.000256	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ITGB3—melanoma	0.000132	0.000256	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SPP1—melanoma	0.00013	0.000251	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAP2K2—melanoma	0.000129	0.000251	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—melanoma	0.000129	0.00025	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL2—melanoma	0.000124	0.000239	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TERT—melanoma	0.000123	0.000238	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RAC1—melanoma	0.000123	0.000238	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKT1—melanoma	0.000121	0.000235	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HIF1A—melanoma	0.000118	0.000228	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KDR—melanoma	0.000113	0.000218	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FN1—melanoma	0.000108	0.00021	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOTCH1—melanoma	0.000106	0.000205	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CD80—melanoma	0.000104	0.000201	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CG—melanoma	0.000104	0.000201	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APC—melanoma	0.000104	0.000201	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KIT—melanoma	0.000104	0.000201	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NRAS—melanoma	0.000104	0.000201	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EGF—melanoma	0.000103	0.000199	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CA—melanoma	0.000101	0.000195	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MAPK3—melanoma	9.93e-05	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BRAF—melanoma	9.75e-05	0.000189	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1—melanoma	9.5e-05	0.000184	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MAPK1—melanoma	9.45e-05	0.000183	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EGFR—melanoma	9.45e-05	0.000183	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAP2K1—melanoma	9.18e-05	0.000178	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CD—melanoma	9.12e-05	0.000177	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CA—melanoma	9.03e-05	0.000175	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—KRAS—melanoma	8.93e-05	0.000173	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGF2—melanoma	8.73e-05	0.000169	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKT1—melanoma	8.24e-05	0.00016	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CA—melanoma	8.2e-05	0.000159	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MDM2—melanoma	8.17e-05	0.000158	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ERBB2—melanoma	8.05e-05	0.000156	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CB—melanoma	7.95e-05	0.000154	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—melanoma	7.64e-05	0.000148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HRAS—melanoma	7.59e-05	0.000147	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN1B—melanoma	7.46e-05	0.000144	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT1—melanoma	7.38e-05	0.000143	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CASP3—melanoma	7.31e-05	0.000142	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2—melanoma	7.3e-05	0.000141	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—melanoma	7.26e-05	0.000141	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCND1—melanoma	7.11e-05	0.000138	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CTNNB1—melanoma	7.05e-05	0.000136	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—melanoma	6.91e-05	0.000134	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN1A—melanoma	6.88e-05	0.000133	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTEN—melanoma	6.87e-05	0.000133	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NFKB1—melanoma	6.83e-05	0.000132	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT1—melanoma	6.7e-05	0.00013	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—melanoma	6.2e-05	0.00012	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STAT3—melanoma	6.14e-05	0.000119	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NRAS—melanoma	6.13e-05	0.000119	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK3—melanoma	5.87e-05	0.000114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MYC—melanoma	5.71e-05	0.000111	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK1—melanoma	5.58e-05	0.000108	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EGFR—melanoma	5.58e-05	0.000108	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KRAS—melanoma	5.27e-05	0.000102	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CA—melanoma	4.84e-05	9.38e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—melanoma	4.69e-05	9.08e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HRAS—melanoma	4.48e-05	8.68e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—melanoma	4.29e-05	8.31e-05	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT1—melanoma	3.96e-05	7.66e-05	CbGpPWpGaD
